The diabetic neuropathy market is dominated by medications, which account for a large share of the market. Painkillers are the most commonly prescribed medication for diabetic neuropathy, and include drugs such as acetaminophen, ibuprofen, and aspirin. Antidepressants such as amitriptyline and duloxetine are also commonly used to treat neuropathic pain. Anticonvulsants such as gabapentin and pregabalin are also effective in treating neuropathic pain. North America and Europe are the largest markets for diabetic neuropathy treatments, due to the high prevalence of diabetes in these regions.
Asia Pacific is also a growing market, driven by the increasing prevalence of diabetes in countries such as India and China. The Diabetic Neuropathy Market is highly competitive, with a large number of players vying for market share. Some of the key players in the market include Pfizer Inc., Novartis AG, Eli Lilly and Company, Johnson & Johnson, Abbott Laboratories, GlaxoSmithKline plc, and Sanofi SA.
Read more @ https://influentialblogging.blogspot.com/2023/04/the-rising-prevalence-of-diabetic.html
